Quest Diagnostics Inc/ US74834L1008 /
| 9/28/2023 9:59:58 PM | Chg. -0.12 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 123.31USD | -0.10% | 25,239 Turnover: 3.12 mill. |
-Bid Size: - | -Ask Size: - | 13.84 bill.USD | 2.14% | 15.23 |
Fundamentals
| FY 2022 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 8.10 USD | -48.90% |
| EPS Diluted: | 7.97 USD | -48.75% |
| Revenues per Share: | 88.78 USD | -1.70% |
| Book Value per Share: | 53.27 USD | -1.85% |
| Cash Flow per Share: | 15.43 USD | -17.44% |
| Dividend per Share: | 2.64 USD | 6.45% |
| Total | in mill. | |
| Revenues: | 9,883.00 USD | -8.39% |
| Net Income: | 946.00 USD | -52.58% |
| Operating Cash Flow: | 1,718.00 USD | - |
| Cash and Cash Equivalents: | 315.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 15.23 | 19.31 |
| P/S Ratio: | 1.39 | 1.76 |
| P/BV ratio: | 2.32 | 2.94 |
| P/CF Ratio: | 7.99 | 10.14 |
| PEG: | -0.31 | -0.40 |
| Earnings Yield: | 6.57% | 5.18% |
| Dividend Yield: | 2.14% | 1.69% |
| Market Capitalization | ||
| Market Capitalization: | 13.84 bill. USD | 17.42 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 112.23 mill. | |
Profitability
| Gross Profit Margin: | 34.74% |
| EBIT Margin: | 14.45% |
| Net Profit Margin: | 9.57% |
| Return on Equity: | 15.95% |
| Return on Assets: | 7.37% |
Financial Strength
| Liquidity I / Cash Ratio: | 20.31% |
| Liquidity II / Quick Ratio: | 97.36% |
| Liquidity III / Current Ratio: | 122.37% |
| Debt / Equity Ratio: | 116.48% |
| Dynam. Debt / Equity Ratio: | 402.04% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 12/31/2022 |
| Accounting Standard: | US GAAP |
| Currency: | USD |